SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 297 filers reported holding SEATTLE GENETICS INC in Q2 2018. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $4,050,000 | +27.1% | 20,696 | +10.3% | 0.01% | +25.0% |
Q2 2020 | $3,187,000 | +64.9% | 18,757 | +11.9% | 0.01% | +33.3% |
Q1 2020 | $1,933,000 | -19.8% | 16,756 | -20.5% | 0.01% | +50.0% |
Q4 2019 | $2,409,000 | +55.5% | 21,083 | +16.2% | 0.00% | +33.3% |
Q3 2019 | $1,549,000 | -34.8% | 18,145 | -47.1% | 0.00% | +200.0% |
Q2 2019 | $2,374,000 | +60.6% | 34,300 | +69.9% | 0.00% | -50.0% |
Q1 2019 | $1,478,000 | +74.3% | 20,185 | +34.8% | 0.00% | +100.0% |
Q4 2018 | $848,000 | -58.9% | 14,969 | -44.0% | 0.00% | -75.0% |
Q3 2018 | $2,063,000 | +47.8% | 26,753 | +27.3% | 0.00% | +33.3% |
Q2 2018 | $1,396,000 | +257.9% | 21,019 | +182.1% | 0.00% | +200.0% |
Q1 2018 | $390,000 | +23.4% | 7,450 | +26.2% | 0.00% | 0.0% |
Q4 2017 | $316,000 | +37.4% | 5,901 | +39.9% | 0.00% | 0.0% |
Q3 2017 | $230,000 | +265.1% | 4,219 | +244.4% | 0.00% | – |
Q2 2017 | $63,000 | -7.4% | 1,225 | +12.9% | 0.00% | – |
Q1 2017 | $68,000 | +51.1% | 1,085 | +26.5% | 0.00% | – |
Q4 2016 | $45,000 | – | 858 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 45,725,556 | $2,365,840,000 | 20.68% |
Lagoda Investment Management, L.P. | 398,529 | $20,620,000 | 7.88% |
Matrix Capital Management Company, LP | 2,118,000 | $109,585,000 | 3.72% |
Ghost Tree Capital, LLC | 300,000 | $15,522,000 | 3.23% |
Sio Capital Management, LLC | 100,000 | $5,174,000 | 2.46% |
GREAT POINT PARTNERS LLC | 249,500 | $12,909,000 | 2.31% |
Redmile Group, LLC | 665,139 | $34,414,000 | 2.10% |
Eventide Asset Management | 525,000 | $27,164,000 | 1.69% |
Opus Point Partners Management, LLC | 35,093 | $1,816,000 | 1.66% |
Boxer Capital, LLC | 125,000 | $6,468,000 | 1.54% |